Avoro Capital Advisors’s Vera Therapeutics VERA Stock Holding History

Avoro Capital Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246M	Sell	5,723,888 -165,000	-3%	-$6.15M	2.21%	15
2026 Q1	$237M	Hold	5,888,888	–	–	2.33%	14
2025 Q4	$298M	Sell	5,888,888 -321,112	-5%	-$11.4M	2.93%	13
2025 Q3	$180M	Sell	6,210,000 -90,000	-1%	-$2.08M	2.33%	15
2025 Q2	$148M	Buy	6,300,000 +598,100	+10%	+$13.4M	2.6%	15
2025 Q1	$137M	Buy	5,701,900 +91,900	+2%	+$2.95M	2.14%	15
2024 Q4	$237M	Buy	5,610,000 +1,300,410	+30%	+$57.6M	3.36%	9
2024 Q3	$190M	Hold	4,309,590	–	–	2.78%	13
2024 Q2	$156M	Sell	4,309,590 -955,410	-18%	-$37.9M	2.08%	16
2024 Q1	$227M	Buy	+5,265,000	New	+$188M	2.65%	16

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Avoro Capital Advisors's VERA Position: Q2 2026 in Review

Avoro Capital Advisors reduced its Vera Therapeutics (VERA) stake by 2.8% in Q2 2026, selling an estimated $6.15M and leaving 5,723,888 shares worth $246M. The position accounts for 2.21% of the portfolio, ranked #15.

Avoro Capital Advisors first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $298M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Avoro Capital Advisors held 5,723,888 shares of Vera Therapeutics worth $246M as of Q2 2026.
Avoro Capital Advisors sold 165,000 Vera Therapeutics shares in Q2 2026, an estimated $6.15M.
Vera Therapeutics made up 2.21% of Avoro Capital Advisors's portfolio in Q2 2026, its #15 holding.
Avoro Capital Advisors first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
Avoro Capital Advisors's Vera Therapeutics position peaked at $298M in Q4 2025.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Avoro Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.